Tokyo, Dec. 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060205) titled 'A review of assessments used in rehabilitation for patients with cancer-related heart disease' on Dec. 25.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - National Cancer Center Hospital East
Condition:
Condition - CTR-CVT
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To comprehensively review assessments used in rehabilitation for patients with onco-cardiology conditions.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Include studies that meet the following framework (PCC)
Population: Patients with cancer therapy-related cardiovascular toxicity (CTR-CVT) who have received rehabilitation.
Concept: Rehabilitation-related assessment outcomes (e.g., physical function assessments, quality of life, activities of daily living).
Context: Studies reported in English or Japanese.
Key exclusion criteria - The following studies will be excluded:
Case reports.
Studies that report only non-rehabilitation assessments (e.g., echocardiography, blood tests).
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 12 Month 25 Day
Anticipated trial start date - 2025 Year 12 Month 25 Day
Last follow-up date - 2026 Year 06 Month 01 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068825
Disclaimer: Curated by HT Syndication.
